Bioequivalence and Bioavailability Forum

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log-in |  Register |  Search

Back to the forum  Query: 2017-07-23 20:42 CEST (UTC+2h)
 

Calculation of Group effect for FDA studies [RSABE / ABEL]

posted by GM - India, 2017-06-09 08:10  - Posting: # 17473
Views: 640

Dear All,

What are necessary terms need to be used in ANOVA model, when the study conducted in cohorts (more than one group)...?

Every time I got confused with this.

Kindly suggest, any guidance is available.

Thanks in advance,
GM

Complete thread:

Back to the forum Activity
 Mix view
Bioequivalence and Bioavailability Forum | Admin contact
17,098 Posts in 3,667 Threads, 1,051 registered users;
15 users online (0 registered, 15 guests).

They must find it difficult… those who have taken authority as the truth,
rather than truth as the authority.    Gerald Massey

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
XHTML/CSS RSS Feed